Product

Drospirenone + Ethinyl Estradiol

Aliases

Drospirenone/Ethinyl Estradiol, Drospirenone+ Ethinyl Estradiol Tablets-Reference product, Drospirenone+ Ethinyl Estradiol Tablets-Test product

2 clinical trials

2 indications

Indication

Healthy Subjects

Indication

Healthy Control Participants

Clinical trial

A Bioequivalence Study of Drospirenone (3 mg) + Ethinyl Estradiol (0.03 mg) Tablets Relative to Yasmin® in Healthy Thai Female Volunteers Under Fasting Condition

Status: Not yet recruiting, Estimated PCD: 2024-04-29

Clinical trial

A Phase 1, Open-label, Fixed-sequence Study to Investigate the Effects of Multiple Doses of BMS-986278 on the Pharmacokinetics of Combined Oral Contraceptives (Drospirenone/Ethinyl Estradiol) in Healthy Female Participants

Status: Completed, Estimated PCD: 2023-12-11